| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
* Department of Clinical Medicine and Cardiovascular Sciences, University of Naples "Federico II" School of Medicine, 80131, Naples, Italy
Department of Clinical and Molecular Endocrinology and Oncology, University of Naples "Federico II" School of Medicine, 80131, Naples, Italy
Increased or reduced action of thyroid hormone on certain molecular pathways in the heart and vasculature causes relevant cardiovascular derangements. It is well established that overt hyperthyroidism induces a hyperdynamic cardiovascular state (high cardiac output with low systemic vascular resistance), which is associated with a faster heart rate, enhanced left ventricular (LV) systolic and diastolic function, and increased prevalence of supraventricular tachyarrhythmias — namely, atrial fibrillation — whereas overt hypothyroidism is characterized by the opposite changes. However, whether changes in cardiac performance associated with overt thyroid dysfunction are due mainly to alterations of myocardial contractility or to loading conditions remains unclear. Extensive evidence indicates that the cardiovascular system responds to the minimal but persistent changes in circulating thyroid hormone levels, which are typical of individuals with subclinical thyroid dysfunction. Subclinical hyperthyroidism is associated with increased heart rate, atrial arrhythmias, increased LV mass, impaired ventricular relaxation, reduced exercise performance, and increased risk of cardiovascular mortality. Subclinical hypothyroidism is associated with impaired LV diastolic function and subtle systolic dysfunction and an enhanced risk for atherosclerosis and myocardial infarction. Because all cardiovascular abnormalities are reversed by restoration of euthyroidism ("subclinical hypothyroidism") or blunted by ß-blockade and L-thyroxine (L-T4) dose tailoring ("subclinical hyperthyroidism"), timely treatment is advisable in an attempt to avoid adverse cardiovascular effects. Interestingly, some data indicate that patients with acute and chronic cardiovascular disorders and those undergoing cardiac surgery may have altered peripheral thyroid hormone metabolism that, in turn, may contribute to altered cardiac function. Preliminary clinical investigations suggest that administration of thyroid hormone or its analogue 3,5-diiodothyropropionic acid greatly benefits these patients, highlighting the potential role of thyroid hormone treatment in patients with acute and chronic cardiovascular disease.
This article has been cited by other articles:
 |
|
 |
|
  Y. J. Park, Y. J. Lee, S.-I. Choi, E.-J. Chun, H. C. Jang, and H.-J. Chang Impact of subclinical hypothyroidism on the coronary artery disease in apparently healthy subjects Eur. J. Endocrinol., July 1, 2011; 165(1): 115 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Hassan Talukder, F. Yang, Y. Nishijima, C.-A. Chen, L. Xie, S. D. Mahamud, A. Kalyanasundaram, J. D. Bonagura, M. Periasamy, and J. L. Zweier Detrimental effects of thyroid hormone analog DITPA in the mouse heart: increased mortality with in vivo acute myocardial ischemia-reperfusion Am J Physiol Heart Circ Physiol, February 1, 2011; 300(2): H702 - H711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Jepson Feline Systemic Hypertension: Classification and pathogenesis Journal of Feline Medicine and Surgery, January 1, 2011; 13(1): 25 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Abdulrahman, V. Delgado, A. C. T. Ng, S. H. Ewe, M. Bertini, E. R. Holman, G. C. Hovens, A. M. Pereira, J. A. Romijn, J. J. Bax, et al. Abnormal cardiac contractility in long-term exogenous subclinical hyperthyroid patients as demonstrated by two-dimensional echocardiography speckle tracking imaging Eur. J. Endocrinol., September 1, 2010; 163(3): 435 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Belakavadi, J. Saunders, N. Weisleder, P. S. Raghava, and J. D. Fondell Repression of Cardiac Phospholamban Gene Expression Is Mediated by Thyroid Hormone Receptor-{alpha}1 and Involves Targeted Covalent Histone Modifications Endocrinology, June 1, 2010; 151(6): 2946 - 2956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Sharma and M. P Agarwal A woman with fatigue, dyspnoea, and orthopnoea BMJ, March 24, 2010; 340(mar24_2): c1277 - c1277. [Full Text]
|
|
|
|
 |
|
 T. Mannisto, M. Vaarasmaki, A. Pouta, A.-L. Hartikainen, A. Ruokonen, H.-M. Surcel, A. Bloigu, M.-R. Jarvelin, and E. Suvanto Thyroid Dysfunction and Autoantibodies during Pregnancy as Predictive Factors of Pregnancy Complications and Maternal Morbidity in Later Life J. Clin. Endocrinol. Metab., March 1, 2010; 95(3): 1084 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Fiore, T Rago, M A Provenzale, M Scutari, C Ugolini, F Basolo, G Di Coscio, P Miccoli, L Grasso, A Pinchera, et al. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients Endocr. Relat. Cancer, February 18, 2010; 17(1): 231 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Oliviero, A. Cittadini, G. Bosso, M. Cerbone, A. Valvano, D. Capalbo, V. Apuzzi, F. Calabrese, T. Lettiero, and M. Salerno Effects of long-term L-thyroxine treatment on endothelial function and arterial distensibility in young adults with congenital hypothyroidism Eur. J. Endocrinol., February 1, 2010; 162(2): 289 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. J. Park, J. W. Yoon, K. I. Kim, Y. J. Lee, K. W. Kim, S. H. Choi, S. Lim, D. J. Choi, K.-H. Park, J. H. Choh, et al. Subclinical Hypothyroidism Might Increase the Risk of Transient Atrial Fibrillation After Coronary Artery Bypass Grafting Ann. Thorac. Surg., June 1, 2009; 87(6): 1846 - 1852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. A. Eustatia-Rutten, E. P. M. Corssmit, K. A. Heemstra, J. W. A. Smit, R. C. Schoemaker, J. A. Romijn, and J. Burggraaf Autonomic Nervous System Function in Chronic Exogenous Subclinical Thyrotoxicosis and the Effect of Restoring Euthyroidism J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2835 - 2841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Iqbal, H. Schirmer, P. Lunde, Y. Figenschau, K. Rasmussen, and R. Jorde Thyroid Stimulating Hormone and Left Ventricular Function J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3504 - 3510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Gammage, J. V. Parle, R. L. Holder, L. M. Roberts, F. D. R. Hobbs, S. Wilson, M. C. Sheppard, and J. A. Franklyn Association Between Serum Free Thyroxine Concentration and Atrial Fibrillation Arch Intern Med, May 14, 2007; 167(9): 928 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-L. Fabrizio, D. B. Vitantonio, T. Enrica, D. C. Andrea, M. Fabio, A. Lucia, P. Caterina, C. Nadia, D. D. M. Grazia, N. Carmela, et al. Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism. Eur. J. Endocrinol., July 1, 2006; 155(1): 3 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nagasaki, M. Inaba, Y. Kumeda, Y. Hiura, K. Shirakawa, S. Yamada, Y. Henmi, E. Ishimura, and Y. Nishizawa Increased Pulse Wave Velocity in Subclinical Hypothyroidism J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 154 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. A. Smit, C. F. A. Eustatia-Rutten, E. P. M. Corssmit, A. M. Pereira, M. Frolich, G. B. Bleeker, E. R. Holman, E. E. van der Wall, J. A. Romijn, and J. J. Bax Reversible Diastolic Dysfunction after Long-Term Exogenous Subclinical Hyperthyroidism: A Randomized, Placebo-Controlled Study J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6041 - 6047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Kahaly and W. H. Dillmann Thyroid Hormone Action in the Heart Endocr. Rev., August 1, 2005; 26(5): 704 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Johansson, M. Rudling, T. S. Scanlan, T. Lundasen, P. Webb, J. Baxter, B. Angelin, and P. Parini Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice PNAS, July 19, 2005; 102(29): 10297 - 10302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Edwards, V. A. Ferraris, D. M. Shahian, E. Peterson, A. P. Furnary, C. K. Haan, and C. R. Bridges Gender-Specific Practice Guidelines for Coronary Artery Bypass Surgery: Perioperative Management Ann. Thorac. Surg., June 1, 2005; 79(6): 2189 - 2194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Santini, A. Pinchera, A. Marsili, G. Ceccarini, M. G. Castagna, R. Valeriano, M. Giannetti, D. Taddei, R. Centoni, G. Scartabelli, et al. Lean Body Mass Is a Major Determinant of Levothyroxine Dosage in the Treatment of Thyroid Diseases J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 124 - 127. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
